Zusammenfassung
Die malignen Tumoren des Corpus uteri umfassen grundsätzlich zwei Gruppen:
-
Endometriumkarzinome,
-
Sarkome des Corpus uteri.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol 56: 419–427
Aalders J, Abeler V, Kolstad P (1984) Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 17: 85
Anderson B, Marchant DJ, Munzenrider JE, Moore JP, Mitchell GW (1976) Routine noninvasive hysterography in the evaluation and treatment of endometrial carcinoma. Gynecol Oncol 4: 354–367
Averette HE, Donate DM, Lovecchio JL, Sevin BU (1987) Surgical staging of gynecologic malignancies. Cancer 60: 2010–2020
Ayoub J, Audet-Lapointe J, Method V et al (1985) Effectiveness of cyclical hormonal therapy in endometrial cancer and its correlation with estrogen-receptor status. Proc Am Soc Clin Oncol 4: 114
Baltzer J, Lohe KJ (1986) Präneoplasien und Karzinome des Endometriums. In: Schmidt- Matthiesen H (Hrsg) Klinik der Frauenheilkunde und Geburtshilfe, Bd 11. Spezielle gynäkologische Onkologie I. Urban & Schwarzenberg, München, S 231–263
Baltzer J, Wolf W, Lohe KJ (1974) Die diagnostische Saug-Kürettage des Uterus. Frauenarzt 3: 194–195
Barber HRK (1982) Cancer of the endometrium. In: van Nageil JR, Barber HRK (eds) Modem concepts of gynecologic oncology. Wright, Boston
Bauer M (1987) Zur intrakavitären Brachytherapie mit Lang- und Kurzzeit-Afterloading-Technik in der Gynäkologie. Gynäkologe 20: 228–236
Bean HA, Bryant AJS (1978) Carcinoma of the endometrium in Saskatchewan: 1966–1971. Gynecol Oncol 6: 503
Boronow RC, Morrow CP, Creasman WT, DeSaia PJ, Silverberg SG, Miller A, Blessing JA (1984) Surgical staging in endometrial cancer: clinical-pathological findings of a prospective study. Obstet Gynecol 83: 825–828
Boutselis JG, Ullery JC, Bair J (1963) Vaginal metastases following treatment of endometrial carcinoma. Obstet Gynecol 51: 339
Bremen T, Waibel S, Leydendecker G (1989) Tumorremission eines endometrialen Stromasarkoms nach Behandlung mit GnRH-Analoga. In: Ludwig H, Krebs D (Hrsg) Gynäkologie und Geburtshilfe 1988: Springer, Berlin Heidelberg New York Tokyo, S 585–586
Bruckmann JE, Goodman RL, Murthy A, Marek A (1979) Combined irradiation and surgery in the treatment of stage II carcinoma of the endometrium. Obstet Gynecol Surv 34:245– 247
Brunner KW (1985) Die internistische Therapie des metastasierenden Mammakarzinoms. In: Büchner T, Urbanitz D, van de Loo J (Hrsg) Therapie des Mammakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 51
Brunner KW (1987) Effects and side effects of chemotherapy in endometrial cancer. In: Schulz KD, King RJB, Poliow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 181–190
Buchsbaum HJ, Lifshitz S, Blythe JG (1976) Prophylactic chemotherapy in stages I and II uterine sarcoma. Gynecol Oncol 8: 346
Butler EB (1976) The early diagnosis of cancer of the endometrium. Clin Obstet Gynecol 3: 389–405
Carlson JA, Allegra JC, Day TG, Wittliff JL (1984) Tamoxifen and endometrial carcinoma: Alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia. Am J Obstet Gynecol 149: 149–153
Cavalli F, Beer M, Martz G, Jungi WF et al. (1983) Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: Report of the Swiss Group for Clinical Cancer Research. Br Med J 286: 5–8
Clarke M (1978) Cancer of the endometrium: epidemiology. In: Brush MG, King RJB,Taylor RW (eds) Endometrial cancer. Bailliére Tindall, London
Cohen G et al. (1984) A randomized study comparing multi-drug chemotherapeutic regimes in the treatment of advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Obstet Gynecol 63: 719
Cramer DW, Cutler SJ (1974) Incidence and histopathology of malignancies of the female genital organs in the United States. Am J Obstet Gynecol 118: 443
Creasman WT, Boronow RC, Morrow CP, DiSaia PJ, Blessing J (1976) Adenocarcinoma of the endometrium: its metastatic lymph node potential. Gynecol Oncol 4: 239–243
Creasman WT, McCarty KS, Barton TK (1980) Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 55: 363–370
Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL (1986) Estrogen replacement therapy in the patients treated for endometrial cancer. Obstet Gynecol 67: 326
Creasman WT, Morrow CP, Bundy L (1987) Surgical pathological spread patterns of endometrial cancer. Cancer 60: 2035
Dallenbach-Hellweg GH, Poulsen H (1985) Tumoren. In: Dallenbach-Hellweg GH, Poulsen H (Hrsg) Atlas der Histopathologic des Endometriums. Springer, Berlin Heidelberg New York, S 166–218
Dallenbach-Hellweg GH, Schmidt-Matthiesen H (1983) Hyperplasien, Präkanzerosen und Karzinome des Endometriums. Dtsch Ges Gynäkologie Geburtshilfe Mitteilg 7: 13–15
Deppe G (1984) Chemotherapy of endometrial carcinoma. In: Deppe G (ed) Chemotherapy of gynecologic cancer. Liss, New York, pp 139–150
DiSaia PJ, Creasman WT (1989a) Adenocarcinoma of the uterus. In: DiSaia PJ, Creasman WT (eds) Synopsis of gynecologic oncology. Mosby, St. Louis, pp 161–197
DiSaia PJ, Creasman WT (1989b) Endometrial hyperplasia. In: DiSaia PJ, Creasman WT (eds) Clinical gynecologic oncology. Mosby, St. Louis, pp 143–160
DiSaia PJ, Creasman WT (1989c) Sarcoma of the uterus. In: DiSaia PJ, Creasman WT (eds) Clinical gynecologic oncology. Mosby, St. Louis, pp 198–213
Ehrlich CE, Cleary RE, Young PCM (1978) The use of progesterone receptors in the management of recurrent endometrial cancer. In: Brush MG, King RJB, Raylor RW (eds) Endometrial cancer. Bailliére-Tindall, London
Ehrlich CE, Young PCM, Stehman FB, Sutton GP, Alford WM (1988) Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 158: 796–805
Fournier D v, Junkermann H, Anton HW (1987) Indikation zur Radiotherapie beim Kollum-und Korpuskarzinom nach Operation. Gynäkologe 20: 222–227
Friedman W (1988) Erkrankungen des Corpus uteri. In: Martius G (Hrsg) Therapie in Geburtshilfe und Gynäkologie, Bd II: Gynäkologie. Thieme, Stuttgart, S 173–186
Frischkorn R (1981a) Die Nachbestrahlung des operierten Zervix- und Endometriumkarzinoms. 43. Vers Dtsch Ges Gynäkol Geburtshilfe. Arch Gynäkol 232: 175
Frischkorn R (1981b) Indikationen der postoperativen Strahlenbehandlung beim Zervix- und Endometriumkarzinom. In: Wannenmacher M (Hrsg) Kombinierte chirurgische und radiologische Therapie maligner Tumoren. Urban & Schwarzenberg, München Wien Baltimore, S 280
Frischkorn R (1983) Die Strahlentherapie des Endometriumkarzinoms. Gynäkologe 16: 104 113
Gilbert H, Kagan AR, Lagasse L, Jacobs MR (1975) The value of radiation therapy in uterine sarcoma. Obstet Gynecol 45: 84
Griesinger RA, Schindler A (1986) Therapie mit Gestagenen bei hyperplastischen Veränderungen des Endometriums. Geburtshilfe Frauenheilkd 46: 690
Gravlee LC (1977) Jet-irrigation method for a diagnosis of endometrial adenocarcinoma: its principle and accuracy. Obstet Gynecol 49: 385–389
Grimshaw RN, Tupper WC, Fräser RC, Tompkins MG, Jeffrey JF (1990) Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol 36: 97–100
Hacker NF (1989) Uterine cancer. In: Berek JS, Hacker NF (eds) Practical gynecologic oncology. Williams & Wilkins, Baltimore, pp 285–326
Haller U, Kubli F, Bräunig G, Müller H, Castaño y Almendral A (1973) Die diagnostische Aspirationskürettage. Geburtshilfe Frauenheilkd 33: 1–13
Hendrickson M et al. (1982) Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6: 93–108
Higdon RE, Averette HE, Donato DM, Penalver MA, Sevin BU (1991) Endometrial cancer: treatment of advanced or recurrent disease with cyclophosphamide, doxorubicin, cis- platinum and megestrol acetate chemotherapy. Obstet Gynecol (in press)
Iversen OE, Segadal E (1985) The value of endometrial cytology. A comparative study of the Gravlee Jet-Washer, Isaacs Cell Sampler and Endoscan versus curettage in 600 patients. Obstet Gynecol Surv 40: 14–20
Jones HW (1975) Treatment of adenocarcinoma of the endometrium. Obstet Gynecol Surv 30: 147
Jordan VC (1987) Antioestrogen for the treatment of endometrial cancer. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 157–164
Kahanpaa KV, Wahlstom T, Grohn P et al. (1986) Sarcoma of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 67: 417
Käser O (1983) Operative Möglichkeiten bei der Therapie des Endometriumkarzinoms. Gynäkologe 16: 99–103
Käser O (1986) Kommentar zur primär operativen Therapie des Korpuskarzinoms. Gynäkologe 19: 94–95
Kaunitz AM, Mosciello A, Ostrowski M, Rovira EZ (1988) Comparison of endometrial biopsy with the endometrial pipette and vabra aspirator. J Reprod Med 33: 427–431
Kauppila A, Vihko R (1987) Estrogen and progestin receptors as prognostic markers in endometrial cancer. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 104–111
Kolstad P (1983) Adjuvant chemotherapy in sarcoma of the uterus: a preliminary report. In: Morrow CP et al. (eds) Recent clinical developments in gynecologic oncology. Raven Press, New York, pp 123–129
Kolstad P (1987) The role of radiation in the treatment of endometrial cancer. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 129–135
Komaki R (1989) The endometrium. In: Moss WT, Cox JD (eds) Radiation oncology. Mosby, St. Louis, Baltimore Toronto, pp 559–580
Koss LG, Schreiber K, Oberlander SG, Moukhtar M, Levine HS, Moussouris HF (1981) Screening of asymptomatic women for endometrial cancer. Obstet Gynecol 57: 681–691
Kurman RJ, Norris HJ (1987) Endometrial hyperplasia and metaplasia. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract. Springer, New York Berlin Heidelberg, pp 322–337
Lauritzen C (1987) Exogenous hormones and endometrial carcinogenesis. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 9–20
Leppien G (1986) Sarkome der weiblichen Genitalorgane. In: Schmidt-Matthiesen H (Hrsg) Klinik der Frauenheilkunde und Geburtshilfe, Bd 11. Spezielle gynäkologische Onkologie I. Urban & Schwarzenberg, München, S 265–281
Lindemann HJ (1980) Atlas der Hysteroskopie. Fischer, Stuttgart
Lochmüller H (1978) Das Endometriumkarzinom als chronische Erkrankung. Wachholz, Nürnberg
Lohe KJ, Baltzer J (1981) Weibliche Genitaiorgane Teil I. In: Hermanek P (Hrsg) Kompendium der klinischen Tumorpathologie, Bd 3. Witzstrock, Baden-Baden
Lohe KJ, Baltzer J, Wolf W, Kürzl R, Tschebiner H (1979) Zur Klinik des Uterussarkoms. Arch Gynecol 228: 651–652
Lohe KJ, Baltzer J, Wolf W, Kürzl R, Tschebiner H (1980) Clinical results in management of patients with uterine sarcomas. Pathol Res Pract 169: 200
Long HJ et al. (1988) Phase II evaluation of carboplatin in advanced endometrial carcinoma. JNCI 80: 276
Lovecchio JL, Averette HE, Lichtinger M, Townsend PA, Girtanner RW, Fenton AN (1984) Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-platinum, and megestrol acetate. Obstet Gynecol 63: 557
Maass H (1987) Epidemiology and etiology. In: Schulz KD, King RJB, Pollow K, Taylor R (eds) Endometrial cancer. Zuckschwerdt, München, pp 3–8
Malkasian GD, Annegeres JF, Fountain FS (1980) Carcinoma of the endometrium: stage I. Am J Obstet Gynecol 136: 872–883
Marchetti DL, Piver MS, Tsukada Y, Reese P (1986) Prevention of vaginal recurrence of stage I endometrial adenocarcinoma with postoperative vaginal radiation. Obstet Gynecol 67: 399–402
Mazurka JL, Krepart GV, Lotocki RJ (1988) Prognostic significance of positive peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol 158: 303–306
Mestwerdt W, Kranzfelder D (1983) Neue diagnostische Möglichkeiten beim Endometriumkarzinom und seinen Vorstufen. Gynäkologe 16: 87–92
Morrow CP, Townsend DE (1987) Tumors of the endometrium. In: Morrow CP, Townsend DE (eds) Synopsis of gynecologic oncology. Churchill Livingstone, New York, pp 159– 205
Morrow CP, DiSaia PJ, Townsend DE (1973) Current management of endometrial carcinoma. Obstet Gynecol 42: 399
Muss HB, Bundy B, DiSaia PJ (1985) Treatment of recurrent or advanced uterine sarcomas: A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase in trial of the Gynecologic Oncology Group). Cancer 55:
Nagell JR van et al. (1986) Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. Cancer 57: 1451
Omura GA et al. (1983) A randomized study of adriamycin with and without dimethyl triazeno-imidazol carboxamide in advanced uterine sarcomas. Cancer 52: 626
Omura GA et al. (1985) A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 9: 1240
Onsrud M, Aalders J, Abeler V, Taylor P (1982) Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment. Gynecol Oncol 13: 76–86
Pasmantier MW, Coleman M, Silver RT, Mamril AP, Quiguyan CC, Galindo A (1984) Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients. Cancer Treat Rep 69: 539–542
Pettersson F, Kolstad P, Ludwig H, Ulfelder H (1985) Annual report on the results of treatment in gynecological cancer. Radiumhemmet, Stockholm, p 19
Pfleiderer A (1981) Die Kombination von Operation und Strahlentherapie aus der Sicht des Operateurs beim Ovarial- und Endometriumkarzinom. In: Wannenmacher M (Hrsg) Kombinierte chirurgische und radiologische Therapie maligner Tumoren. Urban & Schwarzenberg, München
Pfleiderer A, Kleine W (1987) Surgical methods and significance of different prognostic criteria. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 119–135
Piver MS, Marchetti DL (1989) Endometrial carcinoma. In: Piver MS (ed) Manual of gynecologic oncology and gynecology. Little, Brown, Boston, pp 87–101
Piver MS, Rose PG (1988) Advanced uterine sarcomas: response to chemotherapy. Eur J Gynecol Oncol 9: 124
Piver MS et al. (1982) Cyclophosphamide, vincristine, adriamycin and dimethyl-triazeno- imidazol carboxamide (CYVADIC) for sarcomas of the female genital tract. Gynecol Oncol 14: 319
Piver MS, Rutledge FN, Copeland L, Webster K et al. (1984) Uterine endolymphatic stromal myosis. A collaborative study. Obstet Gynecol 64: 173
Piver MS et al. (1988) The effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas. J Surg Oncol 38: 233
Potish et al. (1987) Radiation of periaortic node metastases in cancer of the uterine cervix and endometrium. Radiology 165: 567–570
Rose PG (1989) Uterine sarcoma. In: Piver MS (ed) Manual of gynecologic oncology and gynecology. Little, Brown, Boston, pp 102–116
Rubens RD, Begent RHJ, Knight RK, Sexton SA, Hayward JL (1978) Combined cytotoxic and progesterone therapy for advanced breast cancer. Cancer 42: 1680–1686
Salazar OM, Dunne ME (1980) The role of radiation therapy in the management of uterine sarcomas. Int J Radiat Oncol Bio Phys 6: 899
Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein ML, Dunne ME, Rudolph JH (1978a) Uterine sarcomas. Analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 42: 1161
Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein M, Dunne ME, Rudolph JH (1978b) Uterine sarcomas. Natural history, treatment and prognosis. Cancer 42: 1152
Samartzis S, Hauser GA (1976) Die Postmenopauseblutung. Geburtsh Frauenheilk 36:326– 333
Schmidt-Matthiesen H (1987) Endometrium-(Korpus)-Karzinom. In: Schmidt-Matthiesen H, Bastert G (Hrsg) Gynäkologische Onkologie. Schattauer, Stuttgart, S 46–66
Schulz KD, Kaiser R (1983) Gegenwärtiger Stand der medikamentösen Behandlung des Endometriumkarzinoms. Gynäkologe 16: 114–118
Schulz KD, Schmidt-Rhode P, Zippel HH, Sturm G (1987) New concepts of adjuvant drug treatment in endometrial cancer. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 169–180
Sevin BU (1986) Primär operative Therapie des Korpuskarzinoms. Gynäkologe 19:88– 93
Sevin BU (1987) Paraaortic lymph node dissection in surgical staging of endometrial carcinoma. In: Takagi S, Friedberg V, Haller U, Knapstein PG, Sevin BU (eds) Gynecologic oncology, surgery and urology. Central Foreign Books, Tokyo, pp 184–189
Sevin BU (1988) Die prätherapeutische Staginglaparotomie. In: Hepp H, Scheidel P, Monaghan JM (Hrsg) Lymphonodektomie in der gynäkologischen Onkologie. Urban & Schwarzenberg, München, S 19–31
Shepherd JH (1989) Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 96: 889–892
Silverberg SG (1989) Carcinosarcoma of the uterus. Int J Gynecol Pathol 9: 1–19
Smith JP et al. (1975) Combined irradiation and chemotherapy for sarcomas of the pelvis in females. AJR 123: 571
Stegner HE (1980) Clinical aspects of uterine sarcomas. Pathol Res Pract 169: 120
Stoll P, Lutz H, Runnebaum B, Wittlinger H (1977) Gynäkologische Erkrankungen im Klimakterium und im Senium. Deutscher Ärzteverlag, Köln
Sutton GP et al. (1987) Malignant papillary lesions of the endometrium. Gynecol Oncol 27: 294
Sutton G, Blessing J, McGurie W, Photopulos G, Rettenmaier M et al. (1988) Phase II trial of ifosphamide and mesna in patients with recurrent or advanced mixed mesodermal tumors of the uterus. Proc Am Soc Clin Oncol 7: 137
Swenerton KD (1987) The treatment of disseminated endometrial carcinoma with tamoxifen. In: Schulz KD, King RIB, Pollow K, Taylor (eds) Endometrial cancer. Zuckschwerdt, München, pp 165–168
Teufel G, Frauer A, Eberl M, Pfleiderer A, Neunhoeffer J (1980) Sarcomas of the female genitalia. Therapy and prognosis. Pathol Res Pract 169: 173
Thigpen JT, Buchsbaum HJ, Mangan C, Blessing JA (1979) Phase II trial of adriamycin in the treatment of advanced or recurent endometrial carcinoma: a Gynecologic Oncology Group study. Cancer Treat Rep 63: 17–21
Thigpen T, Vance R, Lambuth B, Ablducci L, Khansur T, Blessing J, McGehee R (1987) Chemotherapy for advanced or recurrent gynecologic cancer. Cancer 60: 2104–2116
Toppozada MK, Ismail AAA, Hamed RSM, Ahmed KS, El-Fares A (1988) Progesteron challenge test and estrogen assays in menopausal women with endometrial adenomatous hyperplasia. Int J Gynecol Obstet 26: 115–119
Vergote I, Korstad K, Abeler V, Kolstad P (1989) A randomized trial of adjuvant progesteron in early endometrial cancer. Cancer 64: 1011–1016
Wyss R, Vassilakos P, Riotton G (1975) Eine neue Aspirationsmethode mit dem Pistolet (zur Früherkennung endometrialer Veränderungen). Geburtshilfe Frauenheilkd 35: 846–853
Zaloudek C, Norris HJ (1987) Mesenchymal tumors of the uterus. In: Kurman RJ, Norris HJ (eds) Blaustein’s pathology of the female genital tract. Springer, New York Berlin Heidelberg, pp 371–408
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Köchli, O.R., Sevin, BU., Benz, J., Petru, E., Haller, U. (1991). Maligne Tumoren des Corpus uteri. In: Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97274-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-97274-4_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97275-1
Online ISBN: 978-3-642-97274-4
eBook Packages: Springer Book Archive